Disclaimer: This site analyses public FDA records. It is not medical advice. If you feel unwell, contact a healthcare professional immediately.
Supplement Safety Checker
Notice: Official Public Record

Coenzyme A, Inc. dba Coenzyme-A Technologies, Inc. FDA Warni

Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on January 05, 2018

CRITICAL SEVERITY Seattle District Office 2018
Disclaimer: This report is an analysis of a public FDA warning letter. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately.

Executive Summary

The FDA issued a warning letter to Coenzyme A, Inc. dba Coenzyme-A Technologies, Inc. on January 05, 2018 citing regulatory violations. Consumers who have purchased products from this company should exercise caution. The letter was issued by Seattle District Office.

Regulatory Violations

Detailed Analysis

False Claims and Regulatory Violations

“The diseases of age that usually cause disability or death such as arthritis, multiple sclerosis, parkinson’s, alzheimer’s, adult on-set diabetes, cancer, artherosclerosis, etc. are usually prevented or alleviated by a well-functioning immune system and healthy DNA. As noted above, Coenzyme-A . . . facilitates the repair of RNA and DNA.”

Komar V. I.; The Use of Pantothenic Acid Preparations in Treating Patients With Viral Hepatitis A; TerArkh 1991; 63: 11, 58-60.

Potential Health Risks

From the article titled “Coenzyme-A and its role in Cardiovascular Health”

Regulatory Context

“Coenzyme-A initiates the fatty acid metabolism . . . essential to the avoidance of the high levels of cholesterol and triglycerides, and the high lipid levels that are characteristic of patients with cardiovascular or diabetic disorders.”

“What are the symptoms of a deficiency of Coenzyme-A? . . . depression, anxiety . . . frequent respiratory infection, cardiac instability, and abnormal need for sleep. Neurological disorders included: numbness, muscle weakness, cramps, abdominal pain and paresthesia (abnormal sensations such as itching and prickling, tingling extremities, and "burning feet" syndrome). Biochemical changes included: . . . lowered blood cholesterol . . . and failure of adrenocorticotropin (ACTH) to induce eosinopenia.”

Key Entities Identified

Coenzyme A Inc. dba Coenzyme-A Technologies Inc. FDA Warning Letter

Frequently Asked Questions

What did the FDA find wrong with Coenzyme A, Inc. dba Coenzyme-A Technologies, Inc.?
The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
Are Coenzyme A, Inc. dba Coenzyme-A Technologies, Inc. products safe to use?
Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
What should I do if I've used Coenzyme A, Inc. dba Coenzyme-A Technologies, Inc. products?
If you have used products from Coenzyme A, Inc. dba Coenzyme-A Technologies, Inc. and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Source Document

This report is based on an official FDA warning letter. The original document is a public record.

View Original FDA Warning Letter
Medical Disclaimer: This report is an analysis of public FDA warning letters. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately. You can report adverse events to the FDA MedWatch program.